The optimal interval for post-vaccination serological test in infants born to mothers with positive hepatitis B surface antigen

References

• Wei KP, Zhu FC, Liu JX, Yan L, Lu Y, Zhai XJ, Chang ZJ, Zeng Y, Li J, Zhuang H. The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: a prospective cohort study. Vaccine. 2018;36(2):256–63. doi:10.1016/j.vaccine.2017.11.037.
   PubMed Web of Science ®Google Scholar
• Cheung KW, Seto MTY, Kan ASY, Wong D, Kou KO, So PL, Lau WL, Jalal K, Chee YY, Wong RMS, et al. Immunoprophylaxis failure of infants born to hepatitis B carrier mothers following routine vaccination. Clin Gastroenterol Hepatol. 2018;16(1):144–45. doi:10.1016/j.cgh.2017.07.013.
   PubMed Web of Science ®Google Scholar
• Xu B, Xu C, Feng J, Chen J, Rui Y, Qiu Z, Zhu J, Tang J, Lou H, Chen T, et al. Reduced mother-to-child transmission of hepatitis B after implementation of completely charge-free active-passive immunoprophylaxis: an observational cohort study. Expert Rev Vaccines. 2021;20(7):899–905. doi:10.1080/14760584.2021.1927723.
   PubMed Web of Science ®Google Scholar
• Immunization Practices Advisory Committee (ACIP). Protection against viral hepatitis: recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep. 1990;39(RR–2):1–26.
   Google Scholar
• Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR–16):1–31.
   PubMedGoogle Scholar
• Schillie S, Murphy TV, Fenlon N, Ko S, Ward JW. Update: shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers. MMWR Morb Mortal Wkly Rep. 2015;64(39):1118–20. doi:10.15585/mmwr.mm6439a6.
   PubMed Web of Science ®Google Scholar
• Ko SC, Schillie SF, Walker T, Veselsky SL, Nelson NP, Lazaroff J, Crowley S, Dusek C, Loggins K, Onye K, et al. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women. Vaccine. 2014;32(18):2127–33. doi:10.1016/j.vaccine.
   PubMed Web of Science ®Google Scholar
• Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. Vaccine. 2013;31(21):2506–16. doi:10.1016/j.vaccine.2012.12.012.
   PubMed Web of Science ®Google Scholar
• Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine. 1995;13(5):443–47. doi:10.1016/0264-410x(94)00010-k.
   PubMed Web of Science ®Google Scholar
• Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006;18:4–9.
   PubMedGoogle Scholar
• Xiao M, Qiu Q, Pang X, Liang X, Li L, Cui F, Wang F, Zhang G, Li H, Wang L, et al. Immune response in infants after universal high-dose hepatitis B vaccination: a community-based study in Beijing, China. Vaccine. 2015;33(43):5878–83. doi:10.1016/j.vaccine.2015.06.018.
   PubMed Web of Science ®Google Scholar
• Euler GL, Copeland JR, Rangel MC, Williams WW. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women. Pediatr Infect Dis J. 2003;22(2):123–29. doi:10.1097/01.inf.0000048677.32881.fa.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008–2011. MMWR Morb Mortal Wkly Rep. 2012;61:768–71.
   PubMedGoogle Scholar
• Nagashima S, Yamamoto C, Ko K, Chuon C, Sugiyama A, Ohisa M, Akita T, Katayama K, Yoshihara M, Tanaka J. Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination. Vaccine. 2019;37(1):145–51. doi:10.1016/j.vaccine.2018.11.019.
   PubMed Web of Science ®Google Scholar
• Hu Y, Xu C, Xu B, Hu L, Liu Q, Chen J, Liu J, Liu L, Yang J, Chen T, et al. Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: a multicenter prospective cohort study. J Viral Hepat. 2018;25(4):429–37. doi:10.1111/jvh.12834.
   PubMed Web of Science ®Google Scholar
• Huang H, Xu C, Liu L, Chen L, Zhu X, Chen J, Feng J, Chen T, Xu B, Yang J, et al. Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus. Clin Infect Dis. 2020;ciaa898. doi:10.1093/cid/ciaa898.
   Web of Science ®Google Scholar
• Huang H, Ning M, Liu J, Chen J, Feng J, Dai Y, Hu Y, Zhou YH. Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: implication for the role of HBeAg as an immunotolerogen. Hum Vaccin Immunother. 2019;15(9):2183–86. doi:10.1080/21645515.2019.1575712.
   PubMed Web of Science ®Google Scholar
• Krugman S, Giles JP, Hammond J. Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin. JAMA. 1971;218(11):1665–70. doi:10.1001/jama.1971.03190240019005.
   PubMed Web of Science ®Google Scholar
• Kamili S, Sozzi V, Thompson G, Campbell K, Walker CM, Locarnini S, Krawczynski K. Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model. Hepatology. 2009;49(5):1483–91. doi:10.1002/hep.22796.
   PubMed Web of Science ®Google Scholar
• Ghaziasadi A, Fakhari Z, Aghcheli B, Poortahmasebi V, Farahmand M, Norouzi M, Ghalichi L, Soleimani A, Hedayat Yaghoobi M, Ravanshad M, et al. High prevalence of occult hepatitis B infection (OBI) among healthy children and their parents in Alborz province, Iran; Vertical OBI, myth or truth? Liver Int. 2020;40(1):92–100. doi:10.1111/liv.14252.
   PubMed Web of Science ®Google Scholar
• Zhou YH. Occult hepatitis B infection in vaccinated children with negative anti-HBc, true or not? Liver Int. 2020;40(10):2570. doi:10.1111/liv.14504.
   PubMed Web of Science ®Google Scholar